https://www.thebodypro.com/author/david-alain-wohl

Latest by David Alain Wohl, M.D.

Promo Image
Lipodystrophy/Body Fat

Body Fat Changes in People With HIV

David Wohl, M.D., talks with Todd Brown, M.D., about research Brown presented at AIDS 2006 regarding body fat changes in people with HIV. Dr. Brown is an assistant professor of medicine at Johns Hopkins School of Medicine; his research focuses on met...

Promo Image

HIV JournalView

Table of Contents

Tenofovir + Emtricitabine + Efavirenz vs. Zidovudine/Lamivudine + Efavirenz Adherence, Viral Fitness and NNRTI and PI Resistance Clinical Course Following Initiation of HIV Therapy: A Comparison of Developed and Developing Nati...

Promo Image
Lipodystrophy/Body Fat

Interventions for Fat Changes: New Research on Glitazones, Metformin and Testosterone

The confusion surrounding the etiology and treatment of HIV-related metabolic complications has been maddening for both patients and their clinicians. Different studies -- typically small and powered for endpoints other than changes in body fat -- ha...

Promo Image

Top 10 Research Publications in HIV Care of 2005

Introduction

Top Published Research of 2005:

HIV Transmission Highest During Acute Infection and End Stage Disease
    Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda
    By Maria J. Wawer, et...
Promo Image

HIV JournalView

Table of Contents

Predicting Risk of Failure Among Those With Low-Level Viremia Screening for HIV Dementia Made Simple People Living (Large) With HIV/AIDS Antiretroviral Therapy and Insulin Resistance: It May Not Be What You Expect Valproic ...

Promo Image

HIV JournalView

Table of Contents

What Is the Best Predictor of Drug Failure? To Control HIV, Test Everyone Don't Combine Fosamprenavir and Lopinavir/Ritonavir Rash, NNRTIs and the 2NN Study Also, a Review Worth Reviewing: Metabolic Complications of HIV and...

Promo Image

Strategies for Switching and Simplifying Antiretroviral Treatment in HIV-Infected Patients: Part II: Case Studies

Part I:

Research Update

Part II: Case Studies

Case 1. Switching From Lopinavir/Ritonavir to Atazanavir + Ritonavir to Manage Increased Lipids Case 2. Switching From Stavudine + Lamivudine + Nevirapine to Tenofovir + Lamivudine + Nevirapine to M...

Promo Image
Viewpoints

Probable Acquisition of Multi-Drug-Resistant HIV in Man With Subsequent Rapid HIV Disease Progression: Reality and Reaction

The case report of a man in New York City who apparently was recently infected with HIV resistant to 3 antiretroviral classes and subsequently suffered rapid progression to AIDS has evoked alarm throughout the community of HIV/AIDS clinicians, resear...

Promo Image

Top 10 Research Reports of 2004

Table of Contents

Introduction AIDS Epidemic Update: December 2004, UNAIDS/WHO Lopinavir/Ritonavir Monotherapy in Treatment-Naive Patients Atazanavir -- The Little PI That Could A5095 and the Triple-Nucleoside Saga The Risk of NNRTI Resist...

Promo Image

HIV JournalView

Table of Contents

Living and Dying in the Time of HAART Prevalence, Incidence and Predictors of K65R Undetectable and in the Dark HCV as a Rationale for C-Section in HIV-Infected Pregnant Women Footnotes

Living and Dying in the Time of HAAR...